
FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's …
Jan 15, 2025 · FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease. January 15, 2025 ... Lilly is a …
Ozempic and Wegovy are no longer in shortage, FDA says
3 days ago · In August, drug manufacturer Eli Lilly began sending cease-and-desist letters to telehealth companies, wellness centers and medical spas selling compounded versions of …
FDA Approves First Medication for Obstructive Sleep Apnea
Today, the U.S. Food and Drug Administration approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity, to be used in...
FDA Approves Lilly's EBGLYSS™ (lebrikizumab-lbkz) for Adults and ...
INDIANAPOLIS, Sept. 13, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today the U.S. Food and Drug Administration (FDA) approved EBGLYSS™ (lebrikizumab …
FDA says tirzepatide shortage is over after taking a second look
Dec 19, 2024 · The Food and Drug Administration said Thursday it’s standing by its earlier decision that the shortage of tirzepatide — the active ingredient in Eli Lilly’s diabetes and …
Lilly's Kisunla™ (donanemab-azbt) Approved by the FDA for the …
INDIANAPOLIS, July 2, 2024 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) approved Kisunla™ (donanemab-azbt, 350 mg/20 mL once-monthly injection for IV infusion), …
FDA approves Eli Lilly’s Zepbound, a weight loss drug similar to ...
Nov 8, 2023 · The Food and Drug Administration on Wednesday approved Zepbound, a new weight loss drug from drugmaker Eli Lilly that was shown in clinical trials to help people lose …
FDA advisers endorse Eli Lilly’s early-stage Alzheimer’s drug ... - CNN
Jun 11, 2024 · On Monday, a panel of independent advisers to the US Food and Drug Administration voted to endorse Eli Lilly’s drug donanemab, a monoclonal antibody designed …
FDA grants accelerated approval to selpercatinib
Jun 17, 2024 · On May 29, 2024, the Food and Drug Administration granted accelerated approval to selpercatinib (Retevmo, Eli Lilly and Company) for pediatric patients two years of age and …
US FDA says Lilly’s weight-loss drug shortage is resolved
Dec 19, 2024 · The U.S. Food and Drug Administration said on Thursday there was no longer a shortage of Eli Lilly’s (LLY.N) blockbuster weight loss and diabetes drugs following a re …
- Some results have been removed